346 related articles for article (PubMed ID: 12664551)
21. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
Rukayadi Y; Yong D; Hwang JK
J Antimicrob Chemother; 2006 Jun; 57(6):1231-4. PubMed ID: 16617064
[TBL] [Abstract][Full Text] [Related]
22. [Antimycotic sensitivities of the clinically isolated candidas].
Akgün Y; Akşit F
Mikrobiyol Bul; 1981 Jul; 15(2):112-20. PubMed ID: 7052253
[TBL] [Abstract][Full Text] [Related]
23. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
[TBL] [Abstract][Full Text] [Related]
24. Anti-Candida activity of Mentha arvensis and Turnera ulmifolia.
Santos KK; Matias EF; Souza CE; Tintino SR; Braga MF; Guedes GM; Nogueira LF; Morais EC; Costa JG; Menezes IR; Coutinho HD
J Med Food; 2012 Mar; 15(3):322-4. PubMed ID: 22082100
[TBL] [Abstract][Full Text] [Related]
25. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
26. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
27. [On the in vitro sensitivity of Candida albicans to nystatin, trichomycin, amphotericin B and gentian violet].
Simon C; Tabrizi SA
Med Welt; 1967 Sep; 37():2164-8. PubMed ID: 5629382
[No Abstract] [Full Text] [Related]
28. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
29. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
Ellepola AN
Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
[TBL] [Abstract][Full Text] [Related]
30. [Fungal infections: involved species and minimal inhibitory concentrations of common antifungal agents].
Dei-Cas E; Fruit J; Poulain D; Dutoit E; Chendid H; Vernes A
Ann Biol Clin (Paris); 1984; 42(6):415-8. PubMed ID: 6543419
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
33. [Sensitivity of yeasts of the genus Candida to new antifungal agents].
Hernández-Molina JM; Llosá J; Martínez-Brocal A; de la Rosa M
Enferm Infecc Microbiol Clin; 1991; 9(7):405-8. PubMed ID: 1799609
[TBL] [Abstract][Full Text] [Related]
34. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
35. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
[TBL] [Abstract][Full Text] [Related]
36. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
37. [Antifungal effect of high molecular weight chitosan on Candida spp isolated from clinical samples].
Tapia CP; Soto DM; Vergara LG; Alburquerque CO; Maccioni AR; Matamata AM; Hermosilla GD; Bucarey SV
Rev Chilena Infectol; 2009 Dec; 26(6):515-9. PubMed ID: 20098785
[TBL] [Abstract][Full Text] [Related]
38. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
Sakellarides E
Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
[TBL] [Abstract][Full Text] [Related]
39. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
40. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
